4 Stocks Driving The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 54 points (0.4%) at 15,287 as of Friday, May 17, 2013, 12:54 PM ET. The NYSE advances/declines ratio sits at 1,992 issues advancing vs. 899 declining with 140 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.5%. Top gainers within the industry include Humana ( HUM), up 2.4%, UnitedHealth Group ( UNH), up 1.8%, Express Scripts ( ESRX), up 1.4%, WellPoint ( WLP), up 1.2% and Intuitive Surgical ( ISRG), up 1.0%. On the negative front, top decliners within the industry include Abbott Laboratories ( ABT), down 1.28, HCA Holdings ( HCA), down 1.27 and Stryker Corporation ( SYK), down 0.62.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry higher today:

4. Mindray Medical International ( MR) is one of the companies pushing the Health Services industry higher today. As of noon trading, Mindray Medical International is up $1.14 (2.86) to $41.23 on heavy volume Thus far, 663,749 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 659,700 shares. The stock has ranged in price between $40.40-$41.43 after having opened the day at $40.50 as compared to the previous trading day's close of $40.09.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $4.6 billion and is part of the health care sector. The company has a P/E ratio of 23.2, above the S&P 500 P/E ratio of 17.7. Shares are up 22.6% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Mindray Medical International a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Mindray Medical International Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

3. As of noon trading, Quest Diagnostics ( DGX) is up $0.87 (1.45) to $60.75 on light volume Thus far, 430,579 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $59.79-$60.77 after having opened the day at $59.86 as compared to the previous trading day's close of $59.88.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $9.5 billion and is part of the health care sector. The company has a P/E ratio of 16.3, below the S&P 500 P/E ratio of 17.7. Shares are up 2.8% year to date as of the close of trading on Thursday. Currently there is 1 analyst that rates Quest Diagnostics a buy, 2 analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Quest Diagnostics Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

2. As of noon trading, Becton Dickinson ( BDX) is up $1.08 (1.07) to $101.58 on light volume Thus far, 418,106 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $100.69-$101.80 after having opened the day at $100.69 as compared to the previous trading day's close of $100.50.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $19.7 billion and is part of the health care sector. The company has a P/E ratio of 18.1, above the S&P 500 P/E ratio of 17.7. Shares are up 28.5% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Becton Dickinson a buy, 5 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Becton Dickinson Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

1. As of noon trading, Cigna ( CI) is up $0.60 (0.89) to $67.96 on light volume Thus far, 671,212 shares of Cigna exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $67.44-$67.96 after having opened the day at $67.44 as compared to the previous trading day's close of $67.36.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $19.4 billion and is part of the health care sector. The company has a P/E ratio of 15.0, below the S&P 500 P/E ratio of 17.7. Shares are up 27.4% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cigna Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
null

If you liked this article you might like

3 Fallen Angels With Chart Appeal

3 Fallen Angels With Chart Appeal

3 Stocks Driving The Health Services Industry Higher

3 Stocks Driving The Health Services Industry Higher

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Mindray Medical International (MR) Downgraded From Buy to Hold

Mindray Medical International (MR) Downgraded From Buy to Hold